Full Alliance Group (OTC: FAGI) Accelerates Commercial Strategy for Aquaox Pure Solutions Featuring Nanobubble HOCl Technology

Rhea-AI Summary

Full Alliance Group (FAGI) has announced significant progress in commercializing its subsidiary Aquaox Pure Solutions' nanobubble-enhanced hypochlorous acid (HOCl) technology. The platform represents an innovative solution targeting the $60 billion global disinfectant and skincare markets. The company's proprietary technology uses stabilized nanobubbles to enhance HOCl's stability and efficacy, creating a clean-label, broad-spectrum antimicrobial solution. Aquaox is pursuing strategic licensing partnerships across healthcare, personal care, industrial, and consumer sectors. The company's Tampa facility is expanding to support branded and white-label production, with applications ranging from personal hygiene to medical-grade disinfection. The technology offers industrial-strength performance with skin-safe application, positioning Aquaox as a platform for scalable innovation in multiple markets.

Positive

• Technology targets a large $60 billion global market opportunity
• Proprietary nanobubble technology enhances HOCl stability and efficacy
• Multiple revenue streams through branded products and strategic licensing opportunities
• Clean-label formula meets growing demand for non-toxic alternatives
• Expanding production facility in Tampa for increased manufacturing capacity

Negative

• Early stage of commercialization with unproven market acceptance
• Potential competition from established disinfectant manufacturers
• Success dependent on securing strategic partnerships and licensing agreements

TAMPA, FL / ACCESS Newswire / June 10, 2025 / Full Alliance Group, Inc. (OTC PINK:FAGI) today announced major strides in the commercial development of its recently formed subsidiary, Aquaox Pure Solutions, LLC. The company's breakthrough nanobubble-enhanced hypochlorous acid (HOCl) platform represents a next-generation solution for the $60 billion global disinfectant and skincare markets.

Aquaox's proprietary approach uses stabilized nanobubbles-microscopic gas-filled structures-to significantly improve the stability and efficacy of HOCl, a naturally occurring antimicrobial agent widely recognized for its safety and broad-spectrum performance. The result is a highly effective, clean-label formula well-suited for a range of fast-growing markets, including hospital-grade disinfection, dermatology, wound care, agriculture, and food safety.

"We believe Aquaox Pure Solutions offers one of the most scalable and investable HOCl technologies available today," said Michel Van Schaik, President of Aquaox Pure Solutions. "Our formulations are clean, potent, and uniquely shelf-stable-offering a meaningful advantage over conventional chlorine-based options."

Built for Scale and Strategic Licensing
Full Alliance Group is exploring strategic licensing and commercialization partnerships with companies across healthcare, personal care, industrial, and consumer sectors. Early-stage discussions with contract manufacturers and brand developers reflect growing interest in safe, sustainable antimicrobial solutions.

As part of its go-to-market strategy, Aquaox Pure Solutions is evaluating categories that include:

• Personal hygiene and pet care

• Oral and skincare health

• Commercial sanitation and food processing

• Medical-grade disinfection and wound care

• Agricultural and environmental purification

Production and Global Readiness
The company's Tampa, Florida-based production facility is expanding to support both branded and white-label formats. With e-commerce-ready packaging and a strict commitment to clean-label ingredients-free from stabilizers, alcohols, or bleach-Aquaox is positioning itself to meet international regulatory standards and rising consumer demand for non-toxic alternatives.

A Platform Technology, Not Just a Product
With its nanobubble HOCl formulations, Aquaox delivers the rare combination of industrial-strength performance and skin-safe application-bridging critical gaps across multiple sectors.

"This isn't just a disinfectant-it's a platform for scalable innovation," said Bill Heneghan. "We see long-term potential to drive licensing revenue while contributing meaningfully to public health and environmental safety."

Media Contact:

Full Alliance Group Inc. Investor Relations

Gabe Rodriguez, Erelations Group
erelationsgroup@gmail.com
(623) 261-9046

Pure Aquaox Solutions, LLC
Brett Phillips
brett@pureaquaox.com
(800) 895-4415

About Full Alliance Group, Inc.

Full Alliance Group, Inc. (OTC:FAGI) is a holding company in the health and wellness sector. FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers.

About Aquaox Pure Solutions, LLC

Aquaox Pure Solutions, LLC is a leading manufacturer of hypochlorous acid products enhanced with nanobubble technology. Committed to sustainability and efficacy, PureAquaox serves diverse markets with applications ranging from healthcare to consumer products.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including but not limited to statements regarding future financial performance, business strategy, and plans and objectives for future operations. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Full Alliance Group, Inc.

View the original press release on ACCESS Newswire

FAQ

What is Full Alliance Group's (FAGI) new technology for disinfectants?

FAGI's subsidiary Aquaox Pure Solutions has developed a nanobubble-enhanced hypochlorous acid (HOCl) technology that improves stability and efficacy for disinfection and skincare applications.

What markets is FAGI targeting with its Aquaox Pure Solutions technology?

The company is targeting multiple markets including hospital-grade disinfection, dermatology, wound care, agriculture, food safety, personal hygiene, and pet care.

How does FAGI plan to commercialize its Aquaox Pure Solutions technology?

FAGI is pursuing strategic licensing partnerships across healthcare, personal care, industrial, and consumer sectors, while expanding its Tampa facility for branded and white-label production.

What is the market size for FAGI's disinfectant technology?

The technology targets the global disinfectant and skincare markets, valued at $60 billion.

What advantages does FAGI's Aquaox technology offer over conventional disinfectants?

The technology offers a clean-label, non-toxic formula free from stabilizers, alcohols, or bleach, while providing industrial-strength performance with skin-safe application.